SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it will present at the BIO CEO & Investor Conference 2009 on Tuesday, February 10, 2009, at 10:00 a.m. Eastern Time at The Waldorf=Astoria Hotel in New York City.
